key: cord-0988417-ttvqu1q6
authors: Yoon, Dukyong
title: Preparing for a New World: Making Friends with Digital Health
date: 2022-01-06
journal: Yonsei Med J
DOI: 10.3349/ymj.2022.63.s108
sha: 680a50b842c264a4827acf4d54616a8491d19379
doc_id: 988417
cord_uid: ttvqu1q6

While digital health solutions have shown good outcomes in numerous studies, the adoption of digital health solutions in clinical practice faces numerous challenges. To prepare for widespread adoption of digital health, stakeholders in digital health will need to establish an objective evaluation process, consider uncertainty through critical evaluation, be aware of inequity, and consider patient engagement. By “making friends” with digital health, health care can be improved for patients.

variable. In clinical practice, it is challenging to achieve the level of performance reported in studies with low-level evidence. For this reason, uptake of digital health solutions has varied greatly. 7 Traditional approaches to generating evidence, such as randomized controlled clinical trials, are impractical because of the short lifespan of digital solutions. 3 Therefore, clinicians need objective criteria for evaluating medical AI. One paper published in JAMIA suggested that the following should be considered: the study population and setting, patient demographics, model architecture, and model evaluation. 8 Regarding model evaluation, it is important to ascertain how internal and external validation was obtained and the degree of transparency. For internal validation, data from the same patients obtained at different time points can be used. However, in this scenario, it is possible that the model will solve classification tasks by learning about the individual characteristics of the patient (unintended pattern) instead of the disease (intended pattern). This could improve internal validation performance, but would present a challenge to external validation. Even if external validation is performed, the generalizability of the model will be limited to the population group described in the external validation dataset. In other words, the reported performance may not be realized in the actual clinical environment. Furthermore, reliable verification of models requires transparency and disclosure of the source code and data used for training the model. However, since digital health care solutions are usually commercialized, disclosure of the entire source code and raw data presents challenges.

Next, when using such critical evaluation, understanding and consideration of the uncertainty included in the digital health solutions are important. When employing digital health solutions, healthcare providers need to be cautious about unconditional dependence (i.e., overreliance or automation bias). 9 While digital health solutions are expected to automate many repetitive tasks in clinical practice, they exhibit limited AI capabilities (i.e., pattern recognition). 10 Many papers report that AI models perform better than medical experts (e.g., radiologists). 11 However, as stated previously, results may differ for patients outside the validation set used by the model (Fig. 1A) . 12, 13 This is because a model forecasts an individual's risk of a given outcome on the basis of a group of individuals with similar features. Therefore, we need to consider differences between the environment where a digital health solution was developed and that in which it intends to be implemented to determine whether it can be adopted successfully. In addition, there ought to be preparations for situations wherein the decision to implement a solution was ultimately inappropriate.

The above-described issues have prompted efforts to reduce errors by calculating uncertainty. 12 In the future, when numerous digital solutions will be part of standard health care, it may be difficult for users to understand the specific features of individual solutions. Therefore, models that can judge whether a prevalence can affect model performance in different patient groups. In this example, recall was decreased when the model was adopted for a low-prevalence group, even though precision was maintained. (C) The implementation of health care solutions varies among hospitals. One hospital may adopt solutions for initial assessments, whereas others may use them for diagnosis or post-monitoring.

given clinical environment is compatible with a digital health solution will be helpful. Accordingly, using several digital health solutions together may be preferable to applying a single one for a specific purpose (Fig. 1A) . However, this will require political and economic decisions about treatment effectiveness and resource value. Alternatively, it may be necessary to establish an AI-based clinical department that determines whether a digital solution is appropriate for the clinical environment, deploys health care solutions based on a hospital's particular situation, and maintains the required environment. 14 Awareness of inequity is also necessary, as it could be a further barrier to adoption of digital solutions. For this, consideration of the characteristics of a population for which a digital solution is designed is needed. 15 Even if a patient's data were in the distribution of the dataset used to develop the model, the prevalence of the disease in the target population could differ from that in the training and validation datasets. This could lead to biased predictions and decisions that differ among groups. 15 For example, the performance of a digital solution may vary depending on the prevalence of the disease (Fig. 1B) . As a result, there may be a group of patients who do not benefit from said solution. Rather than focusing solely on the positives of digital health solutions, we should also consider strategies that help patients who may not benefit from these solutions.

The actual incorporation of digital health into clinical practice is another important issue. Patient care can be more complex and diverse than expected. This is because patient care is optimized for an individual hospital and department. The characteristics of individuals in an organization and of a patient group, as well as aspects of management, may affect the situation in a hospital or department. For this reason, hospitals use a variety of information technologies (e.g., EHRs) or adapt external solutions for their specific environment.

Digital solutions will develop in a similar manner (Fig. 1C) . A solution that does not fit into existing work processes will not be used by clinicians, regardless of its quality. 10, 16 Because work processes differ among hospitals and departments, widespread deployment of an inflexible solution will be challenging. If a model is used in a clinical setting that differs from the environment in which it was designed, the results could fall far short of the reported performance.

Lastly, patient engagement in digital health and consideration of older individuals who are not familiar with digital technologies must be addressed. Current digital health solutions are driven mainly by medical staff and the IT industry. However, patients will ultimately benefit from these solutions. 16 There are also many instances of programs being used by patients. Solutions preferred by patients will eventually become more popular, so patient opinions should be considered when developing and implementing solutions in hospitals.

In conclusion, widespread adoption of digital health appears to be inevitable. Our approach to the adoption and use of digital health will determine whether it improves patient health and makes hospitals more competitive by increasing their efficiency. In Korea, a government-level project called the Korean New Deal has started, and as part of that project, an investment of 200 billion won by 2025 has been planned to aid in the development of healthcare AI models and to support smart hospitals that adopt digital healthcare solutions. 17 As a part of these current efforts, we should continue to strive to make friends with digital health.

Dukyong Yoon https://orcid.org/0000-0003-1635-8376

Information quality frameworks for digital health technologies: systematic review

Future and development direction of digital healthcare

Challenges for the evaluation of digital health solutions-A call for innovative evidence generation approaches

Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries

Backslide or forward progress? Virtual care at U.S. healthcare systems beyond the COVID-19 pandemic

Physician requirements for adoption of telehealth following the SARS-CoV-2 pandemic

Actionable health app evaluation: translating expert frameworks into objective metrics

MINIMAR (MINimum Information for Medical AI Reporting): developing reporting standards for artificial intelligence in health care

Automation bias: a systematic review of frequency, effect mediators, and mitigators

A short guide for medical professionals in the era of artificial intelligence

Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms

Artificial intelligence sepsis prediction algorithm learns to say "I don't know

Second opinion needed: communicating uncertainty in medical machine learning

The clinical artificial intelligence department: a prerequisite for success

Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase Dukyong Yoon

Government of the Republic of Korea. The Korean new deal: national strategy for a great transformation